Rachelle JacquesCEO at Enzyvant
Rachelle joined Enzyvant as CEO from Alexion Pharmaceuticals, Inc., where she most recently served as Senior Vice President and Global Franchise Head of Complement across therapeutic areas of hematology, nephrology and neurology. She brings broad experience in US and Global commercial leadership, including multiple high-profile product launches in rare diseases. Previously, Ms. Jacques was Vice President of U.S. Hematology Marketing at Shire and Baxalta, and Vice President, Business Operations for the Global Bioscience Business Unit at Baxter International. Rachelle has lived and worked in the US, Belgium and China. She started her career in finance and has a BA in Business Administration with an emphasis in Accounting from Alma College. Rachelle also serves on the board of Corbus Pharmaceuticals.